<DOC>
	<DOCNO>NCT02719210</DOCNO>
	<brief_summary>All child acute liver failure candidate transplant constraint transplant randomize either receive standard medical therapy high volume plasma exchange along standard medical therapy aim ass effect high volume plasma exchange transplant free survival .</brief_summary>
	<brief_title>High Volume Plasma Exchange Children With Acute Liver Failure</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Liver Failure , Acute</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>Children ≥ 10kg ALF INR ≥ 4 INR ≥ 3 Hepatic Encephalopathy . 1 . Evidence active infection ( Age specific neutrophilic leucocytosis ( ANC ) procalcitonin ≥ 2 and/or focus active infection 2 . Refusal consent assent ( annexure 3 ) 3 . Liver resection liver failure 4 . Patients clinical suspicion irreversible brain injury 5 . Patients acute kidney injury</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>